Bausch + Lomb Corp
NYSE:BLCOView on Canadian Exchange

  • LAST PRICE
    15.8400
  • TODAY'S CHANGE (%)
    -0.1000 (-0.6274%)
  • Bid / Lots
    15.0000/ 1
  • Ask / Lots
    17.0000/ 1
  • Open / Previous Close
    15.9300 / 15.9400
  • Day Range
    15.7550
    16.0100
  • 52 Week Range
    13.1600
    21.1100
  • Volume
    262,459

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BLCO
Bausch + Lomb Corp
5.6B
-16.5x
---
XRAY
DENTSPLY SIRONA Inc
5.3B
-57.2x
---
MASI
Masimo Corp
6.0B
74.4x
-15.37%
MMSI
Merit Medical Systems Inc
5.0B
49.1x
+14.05%
HAE
Haemonetics Corp
4.6B
39.4x
+17.09%
GKOS
Glaukos Corp
6.1B
-42.8x
---
As of 2024-07-15

Company Information

Bausch + Lomb Corporation is an eye health company. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. The Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Contact Information

Headquarters
520 Applewood CrescentVAUGHAN, ON, Canada L4K 4B4
Phone
---
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Brenton Saunders
Chief Financial Officer, Executive Vice President
Sam Eldessouky
President of Ophthalmic Pharmaceuticals
Andrew Stewart
Executive Vice President, Chief Legal Officer
A. Robert Bailey
Executive Vice President - Research & Development, Chief Medical Officer
Yehia Hashad

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$5.6B
Revenue (TTM)
$4.3B
Shares Outstanding
351.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.96
Book Value
$19.52
P/E Ratio
-16.5x
Price/Sales (TTM)
1.3
Price/Cash Flow (TTM)
71.9x
Operating Margin
3.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.